Recent Quotes

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is a gene therapy company dedicated to developing and commercialising novel treatments for patients suffering from dermatological diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		-0.680		-0.740		-0.0600
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
KRYS	Krystal Biotech	63.40	0.00	0%		1.4B

Krystal Biotech Frequently Asked Questions

How do I buy Krystal Biotech (KRYS) stock?

You can purchase shares of Krystal Biotech (NASDAQ: KRYS) through any online brokerage.

View our list of the best stock brokerages.

Who are Krystal Biotech's (KRYS) competitors?

Other companies in Krystal Biotech’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Humanigen (NASDAQ:HGEN), Arcutis Biotherapeutics (NASDAQ:ARQT) and Regenxbio (NASDAQ:RGNX).

What is the target price for Krystal Biotech (KRYS) stock?

The latest price target for Krystal Biotech (NASDAQ: KRYS) was reported by HC Wainwright & Co. on March 1, 2021. The analyst firm set a price target for 103.00 expecting KRYS to rise to within 12 months (a possible 62.46% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Krystal Biotech (KRYS)?

The stock price for Krystal Biotech (NASDAQ: KRYS) is $63.4 last updated Tue Jun 15 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Krystal Biotech (KRYS) pay a dividend?

There are no upcoming dividends for Krystal Biotech.

When is Krystal Biotech (NASDAQ:KRYS) reporting earnings?

Krystal Biotech’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Krystal Biotech (KRYS) going to split?

There is no upcoming split for Krystal Biotech.

What sector and industry does Krystal Biotech (KRYS) operate in?

Krystal Biotech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.